Tehran University of Medical Sciences

Science Communicator Platform

Share By
Covid-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases Publisher Pubmed



Ghiasvand F1 ; Ghadimi M2 ; Sadr S3 ; Jafari F3, 4 ; Manafi N4 ; Ahmadinejad Z1 ; Tirgar S5 ; Seyedalinaghi S6
Authors

Source: Infectious Disorders - Drug Targets Published:2021


Abstract

Background: Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. Case Presentation: We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful out-come. Conclusion: We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is need-ed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19. © 2021 Bentham Science Publishers.
Other Related Docs
5. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
8. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
9. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
12. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
19. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)